首页 | 本学科首页   官方微博 | 高级检索  
检索        

加味四君子汤含药血清对肝癌Hep-G2细胞的影响
引用本文:施胜英,林海桢,周溦,王素丽,林敬明.加味四君子汤含药血清对肝癌Hep-G2细胞的影响[J].中国实验方剂学杂志,2016,22(18):88-93.
作者姓名:施胜英  林海桢  周溦  王素丽  林敬明
作者单位:南方医科大学 珠江医院, 广州 510280;广州医科大学 附属第三医院, 广州 510150,南方医科大学 珠江医院, 广州 510280,南方医科大学 珠江医院, 广州 510280,南方医科大学 珠江医院, 广州 510280,南方医科大学 珠江医院, 广州 510280
基金项目:广东省自然科学基金项目(S2013010014796);广州市海珠区科普计划项目(2014HZKP-DS-2)
摘    要:目的:探讨加味四君子汤含药血清对肝癌Hep-G2细胞增殖、凋亡、周期的影响及其作用机制。方法:不同浓度加味四君子汤含药血清处理Hep-G2细胞后,采用细胞活性检测试剂盒(CCK-8)检测细胞增殖;Annexin V/碘化丙啶(PI)流式细胞术检测细胞凋亡率和周期;hoechst33342荧光染色观察细胞凋亡形态;免疫印迹法(Western blot)检测细胞中磷脂酰肌醇3-激酶(PI3K)/蛋白激酶B(Akt)/雷帕霉素靶蛋白(m TOR)信号通路相关蛋白表达水平。结果:加味四君子汤含药血清呈浓度依赖性抑制肝癌Hep-G2细胞的增殖,诱导Hep-G2细胞凋亡,阻滞细胞于G0/G1期。hoechst33342染色后,随着含药血清浓度的增加,Hep-G2细胞核显著呈碎块状致密浓染。同时,加味四君子汤含药血清能够抑制Hep-G2细胞Akt,m TOR,核糖体S6蛋白激酶(S6),真核翻译起始因子4E结合蛋白1(4EBP1)的磷酸化,从而上调Bcl-2相关X蛋白(Bax)和下调细胞周期蛋白(Cyclin D1),B淋巴细胞瘤-2(Bcl-2)的表达。加味四君子汤含药血清与300 nmol·L-1的PI3K/m TOR双重抑制剂VS-5584联合使用具有协同作用,含药血清能增强PI3K/m TOR双重抑制剂VS-5584对Hep-G2细胞中PI3K/Akt/m TOR信号通路靶点Akt和m TOR磷酸化的抑制作用。结论:加味四君子汤含药血清能抑制Hep-G2细胞的增殖,诱导其凋亡,阻滞其于G0/G1期,其机制可能通过阻断PI3K/Akt/m TOR信号通路而实现。

关 键 词:加味四君子汤  含药血清  肝癌HepG2细胞  增殖  凋亡  磷脂酰肌醇3-激酶/蛋白激酶B/雷帕霉素靶蛋白信号通路
收稿时间:2016/4/13 0:00:00

Effect of Jiawei Sijunzi Decoction Containing Serum on Human Hepatocellular Carcinoma Hep-G2 Cells
SHI Sheng-ying,LIN Hai-zhen,ZHOU Wei,WANG Su-li and LIN Jing-ming.Effect of Jiawei Sijunzi Decoction Containing Serum on Human Hepatocellular Carcinoma Hep-G2 Cells[J].China Journal of Experimental Traditional Medical Formulae,2016,22(18):88-93.
Authors:SHI Sheng-ying  LIN Hai-zhen  ZHOU Wei  WANG Su-li and LIN Jing-ming
Institution:Zhujiang Hospital of Southern Medical University, Guangzhou 510280, China;The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China,Zhujiang Hospital of Southern Medical University, Guangzhou 510280, China,Zhujiang Hospital of Southern Medical University, Guangzhou 510280, China,Zhujiang Hospital of Southern Medical University, Guangzhou 510280, China and Zhujiang Hospital of Southern Medical University, Guangzhou 510280, China
Abstract:Objective: To investigate the effects of Jiawei Sijunzi decoction containing serum on proliferation, apoptosis, and cell cycle of human hepatocellular carcinoma Hep-G2 cells and explore its action mechanism. Method: After Hep-G2 cells were processed with different concentrations of Jiawei Sijunzi decoction containing serum, cell counting kit-8(CCK-8) was used to measure the proliferation of Hep-G2 cells, apoptosis rate and cell cycle were detected by AnnexinV/propidium iodide(PI) flow cytometry. Apoptotic morphology was determined by hoechst33342 staining. The expression levels of related proteins of phosphatidylinositol 3-kinase(PI3K)/protein kinase B(Akt)/mammalian target of rapamycin(mTOR) signaling pathway in Hep-G2 cells were evaluated by Western blot assay. Result: Jiawei Sijunzi decoction containing serum inhibited the proliferation and induced apoptosis of human hepatoma Hep-G2 cells in a dose-dependent manner. Cells were arrested in G0/G1 phase. Hoechst33342 staining results showed prominent morphological changes with chromatin condensation, fragmentation and formation of apoptotic bodies in dose-dependent manner. Western blot analysis showed that Jiawei Sijunzi decoction containing serum could inhibit phosphorylation of Akt, mTOR, ribosomal S6 kinase(S6), and eukaryotic translation initiation factor 4E-binding protein 1(4EBP1), up-regulate the expression levels of Bax, and down-regulate the expression levels of CyclinD1, Bcl-2. Jiawei Sijunzi decoction containing serum and PI3K/mTOR dual inhibitor VS-5584 had a synergism effect, and Jiawei Sijunzi decoction containing serum enhanced the inhibitory effects on phosphorylation of Akt and mTOR. Conclusion: Jiawei Sijunzi decoction containing serum could inhibit the proliferation of Hep-G2 cells, induce apoptosis and arrest Hep-G2 cells in G1 phase. This inhibitory effect may be induced by blocking the PI3K/Akt/mTOR pathway.
Keywords:Jiawei Sijunzi decoction  containing serum  Hep-G2 cells  proliferation  apoptosis  phosphatidylinositol 3-kinase(PI3K)/protein kinase B(Akt)/mammalian target of rapamycin(mTOR) signaling pathway
本文献已被 CNKI 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号